Table 2

Clinical characteristics of 247 patients with asthma reviewed by A-CARE, September 17 to January 19

Age (years)
 Mean±1 SD48.4±18.8
Usual asthma follow-up prior to ED visit
 Primary care (polyclinic or general practitioner)9940.1%
Smoking status
 Current smoker7128.7%
No history of asthma counselling18574.9%
Inhaled treatment status prior to ED visit
 Not on any form of treatment208.1%
 On bronchodilators (SABA or SAMA) without controller therapy6727.1%
 On any form of controllers (ICS or LTRA)15964.4%
  ICS only3413.8%
  Combination therapy (ICS/LABA) only8434%
  Combination (ICS/LABA) with LTRA239.3%
  Combination (ICS/LABA) with LAMA83.2%
  Combination (ICS/LABA)+LAMA+LTRA104%
2 ED visits in the past 1 year for asthma exacerbation5522.3%
>2 ED visits in the past 1 year for asthma exacerbation4217%
ED disposition(n=273)
 Discharged against advice, absconded or demised155.5%
 Discharged from ED12545.8%
  Discharged from ED with OCS10584%
  Discharged from ED with ICS9676.8%
  Outpatient follow-up issued10886.4%
  • A-CARE, Asthma-COPD Afterhours Respiratory Nurse at Emergency; ED, emergency department; ICS, inhaled corticosteroids; LABA, long-acting beta2-agonist; LAMA, long-acting muscarinic antagonist; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroids; SABA, short-acting beta2-agonist; SAMA, short-acting muscarinic antagonist.